Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Dispatch Bio, founded in 2022, is driven by a bold mission: create a world where all solid tumor cancer patients can be cured. Using our first‑in‑class Flare platform, we combine a tumor-specific viral vector with immunotherapy to tag and eliminate cancer cells precisely and powerfully. Based in Philadelphia and San Francisco, we collaborate with world‑class researchers and operate at the convergence of cutting‑edge sc...
Dispatch Bio, founded in 2022, is driven by a bold mission: create a world where all solid tumor cancer patients can be cured. Using our first‑in‑class Flare platform, we combine a tumor-specific viral vector with immunotherapy to tag and eliminate cancer cells precisely and powerfully. Based in Philadelphia and San Francisco, we collaborate with world‑class researchers and operate at the convergence of cutting‑edge science and translational impact.

List your booth number for exhibitions, ask us